AJINY News and Press, Ajinomoto Co. Inc. ADR From 02/22/23

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase PR Newswire TOKYO , Feb. 22, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufac...

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer PR Newswire TOKYO , Jan. 10, 2023 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co.") today announced a license agreeme...

The shares in PLAID have corrected over 80% YTD, but fundamentals remain negative. The company's CX SaaS metrics point to low customer success, and management has highlighted its competitive weakness versus peers in terms of price and value. Despite the shares trading on Price to ...

Ajinomoto Cambrooke a wholly owned subsidiary of Ajinomoto Health & Nutrition North America, member of The Ajinomoto Group (AJINY) has acquired Nualtra Limited, a medical nutrition company offering life-enhancing oral nutritional supplements in the UK and Ireland The acquis...